Exhibit 10.1
* The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission.
N62645-12-C-4079
P00001
Page 2 of 4
SECTION SF 30 BLOCK 14 CONTINUATION PAGE
SUMMARY OF CHANGES
SECTION A - SOLICITATION/CONTRACT FORM
The total cost of this contract was decreased by $2,099,893.01 from $3,519,999.60 to $1,420,106.59.
SECTION B - SUPPLIES OR SERVICES AND PRICES
CLIN 0001
The pricing detail quantity has decreased by [*]from [*]to [*].
The total cost of this line item has decreased by $183,955.76 from $827,800.92 to $643,845.16.
CLIN 0002
The pricing detail quantity has decreased by [*] from [*]to [*].
The total cost of this line item has decreased by $1,841,670.86 from $2,600,005.92 to $758,335.06.
CLIN 0003
The pricing detail quantity has decreased by [*] from [*]to [*].
The total cost of this line item has decreased by $74,266.39 from $92,192.76 to $17,926.37.
SECTION F - DELIVERIES OR PERFORMANCE
The following Delivery Schedule item for CLIN 0001 has been changed from:
| | DELIVERY DATE | QUANTITY | SHIP TO ADDRESS | UIC |
| | | | | |
| | POP [*]TO [*] | N/A | NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVENUE SILVER SPRING MD 20910 FOB: Destination | N32398 |
| | | | | |
| To: | | | | |
| | | | | |
| | DELIVERY DATE | QUANTITY | SHIP TO ADDRESS | UIC |
| | | | | |
| | POP [*]TO [*] | N/A | NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVENUE SILVER SPRING MD 20910 FOB: Destination | N32398 |
* The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission.
N62645-12-C-4079
P00001
Page 3 of 4
The following Delivery Schedule item for CLIN 0002 has been changed from:
| | DELIVERY DATE | QUANTITY | SHIP TO ADDRESS | UIC |
| | | | | |
| | [*]TO [*] | N/A | NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVENUE SILVER SPRING MD 20910 FOB: Destination | N32398 |
| | | | | |
| To: | | | | |
| | | | | |
| | DELIVERY DATE | QUANTITY | SHIP TO ADDRESS | UIC |
| | | | | |
| | [*]TO [*] | N/A | NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVENUE SILVER SPRING MD 20910 FOB: Destination | N32398 |
The following Delivery Schedule item for CLIN 0003 has been changed from:
| | DELIVERY DATE | QUANTITY | SHIP TO ADDRESS | UIC |
| | | | | |
| | POP 29-SEP-2012 TO 28-SEP-2015 | N/A | NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVENUE SILVER SPRING MD 20910 FOB: Destination | N32398 |
| | | | | |
| To: | | | | |
| | | | | |
| | DELIVERY DATE | QUANTITY | SHIP TO ADDRESS | UIC |
| | | | | |
| | POP 29-SEP-2012 TO 30-JUL-2013 | N/A | NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVENUE SILVER SPRING MD 20910 FOB: Destination | N32398 |
SECTION G - CONTRACT ADMINISTRATION DATA
Accounting and Appropriation
Summary for the Payment Office
As a result of this modification, the total funded amount for this document was decreased by $2,099,893.01 from $3,519,999.60 to $1,420,106.59.
* The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission.
N62645-12-C-4079
P00001
Page 4 of 4
CLIN 0001:
AA: 1721319 B521 255 32398 0 068688 2D CAP009 323982AB508Q (CIN N3239812RCAP0090001) was decreased by $183,955.76 from $827,800.92 to $643,845.16
CLIN 0002:
AA: 1721319 B521 255 32398 0 068688 2D CAP009 323982AB508Q (CIN N3239812RCAP0090002) was decreased by $1,841,670.86 from $2,600,005.92 to $758,335.06
CLIN 0003:
AA: 1721319 B521 255 32398 0 068688 2D CAP009 323982AB508Q (CIN N3239812RCAP0090003) was decreased by $74,266.39 from $92,192.76 to $17,926.37
(End of Summary of Changes)
* The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission.
